Admitting Conference: 45-Year-Old Female with Typhoid Fever
Initial Assessment and Diagnosis
This patient requires immediate blood culture collection (2-3 specimens of 20 mL each) before initiating empiric antibiotic therapy, as blood culture remains the gold standard for typhoid diagnosis despite the positive IgM serology. 1
Clinical Presentation Analysis
- Fever, vomiting, and headache are classic presenting features of typhoid fever, with fever present in 97-100% of cases 2, 3
- The 2-day history represents early disease (typical incubation period is 7-18 days, with insidious onset over 3-7 days) 2, 4
- Positive typhoid IgM alone is insufficient for definitive diagnosis—the Widal test and serologic testing have limited specificity and should not be used as sole diagnostic criteria 2, 1
Critical Diagnostic Steps
- Obtain blood cultures immediately (before antibiotics): 2-3 specimens of 20 mL each in adults, as bacteremia is low (0.3 CFU/mL) 1
- Collect stool and urine cultures as adjunctive diagnostic specimens 1
- Assess for severe disease indicators: fever ≥38.5°C, signs of septic shock, altered mental status/encephalopathy 1, 5
- Monitor for complications: intestinal perforation (typically week 3 if untreated), GI bleeding, encephalopathy (occurs in 10-15% of patients) 2, 1
Treatment Algorithm
Severity Stratification
For severe cases (sepsis, fever ≥38.5°C, septic shock, or encephalopathy):
- Start IV ceftriaxone immediately after obtaining cultures 1
- Dose: 2-4 g IV daily 5, 6
- This patient may require this approach given the vomiting and potential for severe disease 1
For uncomplicated cases:
- Treatment choice depends on travel history and regional resistance patterns 1
First-Line Antibiotic Selection
If travel from or residence in South/Southeast Asia (high fluoroquinolone resistance):
- Azithromycin 500 mg once daily for 7-14 days is first-line, with superior efficacy and lower clinical failure/relapse rates 1, 6
- Alternative for severe cases: IV ceftriaxone (relapse rate <8%) 1
- Do NOT use fluoroquinolones due to widespread resistance in this region 1, 4
If travel from other regions with confirmed susceptibility:
- Ciprofloxacin 500-750 mg twice daily for 14 days (fever clearance <4 days, cure rates >96%) 1, 7
- Ofloxacin is an alternative fluoroquinolone 1
Treatment Duration and Monitoring
- Continue treatment for 14 days to reduce relapse risk 1
- Expected fever clearance: 4-5 days with appropriate therapy 1
- If fever persists beyond 5 days, consider drug resistance and switch therapy 6
Supportive Care and Monitoring
Immediate Management
- IV fluid resuscitation if signs of dehydration from vomiting 5
- Antiemetics for symptomatic relief of vomiting
- Monitor vital signs closely for development of septic shock (may require vasopressor support with dopamine) 5
Laboratory Monitoring
- Daily complete blood count: watch for leukopenia, thrombocytopenia (common in typhoid) 5, 6
- Electrolytes: monitor for hyponatremia 6
- Liver function tests: hepatitis can occur 5
- Coagulation studies if bleeding complications suspected 5
Neurologic Monitoring
- Serial neurologic examinations for encephalopathy development 2, 5
- Consider head imaging if altered mental status develops (rare cases of cerebral venous thrombosis reported) 8
- Steroids may be beneficial in severe typhoid with toxic delirium 9
Infection Control and Public Health
Isolation Precautions
- Contact precautions with gloves and gowns 10
- Hand hygiene with soap and water (alcohol-based sanitizers less effective for enteric pathogens) 10
- Private room preferred to prevent transmission 10
Public Health Notification
- Typhoid fever is a nationally notifiable disease—report to local/state health department immediately 10
- Submit isolates (if cultures positive) to public health laboratory for antimicrobial susceptibility testing and molecular typing 10
- Identify potential source: recent travel history, food exposures, contact with known carriers 10
Common Pitfalls to Avoid
Diagnostic Pitfalls
- Do not rely on IgM serology alone—blood culture is essential despite lower sensitivity (40-80%) 1
- Do not delay cultures for serology results—obtain cultures before starting antibiotics 1
- Do not miss complications: abdominal pain may indicate perforation; altered mental status may indicate encephalopathy or cerebral thrombosis 2, 5, 8
Treatment Pitfalls
- Do not use fluoroquinolones empirically without knowing travel history—resistance is widespread in South/Southeast Asia 1, 4
- Do not use short treatment courses (<14 days)—increases relapse risk 1
- Do not assume fever clearance means cure—complete the full 14-day course 1
- Do not overlook multi-drug resistance—if fever persists beyond 5 days on appropriate therapy, consider resistance and switch antibiotics 6
Monitoring Pitfalls
- Do not discharge before fever clearance—complications can develop in week 2-3 2
- Do not ignore persistent fever—may indicate inadequate therapy, resistance, or complications 6
Disposition Planning
Criteria for Continued Hospitalization
- Persistent fever or vomiting requiring IV therapy
- Signs of complications: abdominal pain (perforation risk), altered mental status, bleeding 2, 1
- Inability to tolerate oral medications 1
Discharge Criteria
- Afebrile for 48-72 hours on appropriate antibiotics
- Tolerating oral intake and medications
- No signs of complications
- Reliable follow-up arranged to complete 14-day antibiotic course 1